SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-095913
Filing Date
2011-04-13
Accepted
2011-04-13 09:01:02
Documents
5
Period of Report
2011-05-24
Effectiveness Date
2011-04-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 736863
2 GRAPHIC g169815g20f99.jpg GRAPHIC 3873
3 GRAPHIC g169815g34p54.jpg GRAPHIC 27729
4 GRAPHIC g169815g38r75.jpg GRAPHIC 8969
5 GRAPHIC g169815g90g11.jpg GRAPHIC 4934
  Complete submission text file 0001193125-11-095913.txt   801215
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 11756166
SIC: 2834 Pharmaceutical Preparations